6
M. Satiraphan et al.
Methyl (24R,25S)-dihydroxy-26-O-nonadecylcarbonyloxy-3,4-secocycloarta-4(28)-en-3-
oate (1a): colourless amorphous solid; ½aꢀD þ 74.0 (c ¼ 0.10, CHCl3); IR (film) nmax cm21
:
20
3500, 2924, 1740, 1456, 1376; 1H-NMR (CDCl3):d 0.41 (1H, d, J ¼ 4.1 Hz, H-19a), 0.73 (1H,
d, J ¼ 4.1 Hz, H-19b), 0.88 (6H, m, 21-CH3, v1-CH3), 0.94 (3H, s, 30-CH3), 0.97 (3H, s, 18-
CH3), 1.09 (1H, m, H-6b), 1.10 (1H, m, H-7a), 1.20 (3H, s, 27-CH3), 1.25 (33H, m, (CH02)16,
H-11b), 1.29 (1H, m, H-16b), 1.30 (2H, m, H-15), 1.31 (2H, m, H-7b, H-22a), 1.38 (1H, m, H-
1a), 1.41 (2H, m, H-20, H-23a), 1.46 (1H, m, H-23b), 1.48 (1H, m, H-22b), 1.53 (1H, m, H-
6a), 1.57 (1H, m, H-8), 1.59 (1H, m, H-17), 1.63 (2H, m, H-30), 1.66 (2H, m, H-12), 1.69 (3H,
s, 29-CH3), 1.90 (1H, m, H-16a), 2.05 (1H, m, H-1b), 2.10 (1H, m, H-11a), 2.27 (1H, ddd,
J ¼ 15.5, 12.0 and 4.0 Hz, H-2a), 2.38 (2H, br t, J ¼ 7.5 Hz, H-20), 2.43 (1H, m, H-5), 2.51
(1H, ddd, J ¼ 15.5, 12.1 and 5.7 Hz, H-2b), 3.42 (1H, br d, J ¼ 8.9 Hz, H-24), 3.65 (3H, s,
CH3-O), 4.04 (1H, br d, J ¼ 11.4 Hz, H-26a), 4.28 (1H, br d, J ¼ 11.4 Hz, H-26b), 4.74 (1H, br
s, H-28a), 4.81 (1H, br s, H-28b). 13C-NMR (CDCl3): 14.2 (C-v1), 18.1 (C-18), 18.2 (C-21),
19.3 (C-30), 19.8 (C-29), 20.7 (C-27), 21.3 (C-9), 22.7 (C-v2), 25.0 (C-30, C-7), 26.9 (C-11),
27.0 (C-10), 27.6 (C-23), 27.8 (C-6), 28.2 (C-16), 29.0 (C-1), 29.2-29.6 (overlap, (CH2)0 14),
30.0 (C-19), 31.4 (C-2), 31.9 (C-v3), 33.0 (C-12), 33.2 (C-22), 34.3 (C-20), 35.6 (C-15), 35.8
(C-20), 45.1 (C-13), 45.8 (C-5), 47.7 (C-8), 49.0 (C-14), 51.4 (C H3-O), 52.3 (C-17), 68.4 (C-
26), 73.9 (C-25), 76.4 (C-24), 111.5 (C-28), 149.5 (C-4), 174.3 (C-10), 174.5 (C-3); ESI-MS:
m/z 822 [M þ Na]þ; HR-ESI-MS: m/z 821.6651 [M þ Na]þ (Calcd for C51H90O6Na
821.6635).
3.5. Saponification of 1a
To a stirred solution of 1a (10.4 mg, 0.013 mmol) in a 1:2 mixture of THF–H2O (3 mL),
LiOH.H2O (1.2 mg, 0.029 mmol) was added at room temperature. Then, the reaction mixture
was heated at 508C for 3 h (TLC monitoring, with cyclohexane–EtOAc (2:1) as eluent), and
then concentrated in vacuo to dryness. The residue was taken up in 3 mL of AcOH–H2O
(3:1) and the resulting solution was extracted twice with 5 mL of CH2Cl2. The solvent was
evaporated under reduced pressure and the oily residue was partitioned between cyclohexane
(3 mL) and a 3:1 mixture of MeOH–H2O (3 mL). Both fractions were concentrated under
reduced pressure to dryness in order to obtain as colourless oils, eicosanoic acid (arachidic
acid, 3 mg) and 1b (6 mg), respectively. The identification of the fatty acid was confirmed by
mass spectrometry analysis (ESI-MS: m/z 311 [M 2 H]2, 623 [2M 2 H]2 (Calcd for
C20H40O2, 312)).
24R,25S,26-Trihydroxy-3,4-secocycloarta-4(28)-en-3-oic (1b):
25
A colourless oil;
½aꢀD þ 52.9 (c ¼ 0.35, CHCl3); IR (film) nmax cm21: 2927, 2867, 1715, 1454, 1443, 1260,
1020, 1010, 820; 1H-NMR (CDCl3): d 0.43 (1H, d, J ¼ 4.3 Hz, H-19a), 0.75 (1H, d, J ¼ 4.3 Hz,
H-19b), 0.90 (3H, d, J ¼ 5.9 Hz, 21-CH3), 0.95 (3H, s, 30-CH3), 0.99 (3H, s, 18-CH3), 1.10 (2H,
m, H-6b, H-7a), 1.12 (3H, s, 27-CH3), 1.25 (1H, H-11b), 1.29 (1H, m, H-16b), 1.31 (2H, m, H-
15), 1.33 (2H, m, H-7b, H-22a), 1.38 (1H, m, H-1a), 1.40 (1H, m, H-23a), 1.44 (1H, m, H-20),
1.47 (1H, m, H-23b), 1.53 (1H, m, H-22b), 1.55 (1H, m, H-6a), 1.58 (1H, m, H-8), 1.61 (1H, m,
H-17), 1.68 (2H, m, H-12), 1.70 (3H, s, 29-CH3), 1.94 (1H, m, H-16a), 2.06 (1H, m, H-1b), 2.11
(1H, m, H-11a), 2.30 (1H, m, H-2a), 2.45 (1H, m, H-5), 2.55 (1H, ddd, J ¼ 15.6, 11.5 and
5.5 Hz, H-2b), 3.50 (2H, m, H-24, H-26a), 3.86 (1H, br d, J ¼ 11.2 Hz, H-26b), 4.75 (1H, br s, H-
28a), 4.83 (1H, br s, H-28b). 13C-NMR (CDCl3): 18.2 (C-18, C-21), 19.3 (C-30), 19.7 (C-29),
21.1 (C-27), 21.3 (C-9), 25.0 (C-7), 26.9 (C-10, C-11), 27.7 (C-6), 28.2 (C-16), 28.7 (C-23), 28.8
(C-1), 30.0 (C-19), 31.3 (C-2), 33.0 (C-12), 33.3 (C-22), 35.7 (C-15), 36.0 (C-20), 45.1 (C-13),
45.9 (C-5), 47.8 (C-8), 49.0 (C-14), 52.5 (C-17), 67.6 (C-26), 74.1 (C-25), 78.6 (C-24), 111.6 (C-
28), 149.4 (C-4), 179.0 (C-3); HR-ESI-MS: m/z 513.3572 [M þ Na]þ (calcd for C30H50O5Na,
513.3556).